Distribution of amiodarone in heart tissues following intrapericardial administration

被引:0
|
作者
Darsinos, JT
Karli, JN
Samouilidou, EC
Krumbholz, B
Pistevos, AC
Levis, GM
机构
[1] Univ Athens, Alexandra State & Univ Hosp, Sch Med, Dept Clin Therapeut, GR-11528 Athens, Greece
[2] Univ Athens, Alexandra State & Univ Hosp, Sch Med, Biochem Res Lab, GR-11528 Athens, Greece
关键词
intrapericardial solution; amiodarone; heart tissue;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The distribution of amiodarone (A) in heart tissues of open chest anesthetized animals was studied at 20 and 60 min following the insertion of an isotonic solution of the drug into the pericardial sac (PS) in doses from 0.25 to 3 mg per kg body weight (BW) for pigs and after 60 min in doses of 3 to 6 mg for dogs. Most of the A absorbed by the myocardium was found in the subepicardium part of the left ventricular (LV) wall. For both species the percentage of drug absorbed by the myocardium was largely and inversely related to the dose given, while uptake by the atria was positively related to the dose and was higher than that in the subepicardial LV wall. Sixty minutes after i.v. administration of A (3.0 mg per kg BW) the drug was evenly distributed across the LV wall (16 mu g per g wet tissue), which was significantly lower (p < 0.02) than that of subepicardal LV wall (30 mu g) after intrapericardial (IP) administration. This study shows that satisfactory drug concentrations in predicted and specific distribution in the heart tissue were derived shortly after intrapericardial administration without measurable circulation in the blood.
引用
收藏
页码:301 / 306
页数:6
相关论文
共 50 条
  • [1] Intrapericardial Delivery of Amiodarone and Sotalol: Atrial Transmural Drug Distribution and Electrophysiological Effects
    Bolderman, Robert W.
    Hermans, J. J. Rob
    Rademakers, Leonard M.
    Jansen, Tim S.
    Verheule, Sander
    van der Veen, Frederik H.
    Maessen, Jos G.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2009, 54 (04) : 355 - 363
  • [2] Low Back Pain Following Intravenous Administration of Amiodarone
    Tsikrikas, Spyros
    Charalampous, Charalampos
    Letsas, Konstantinos P.
    Efremidis, Michalis
    Sideris, Antonios
    HELLENIC JOURNAL OF CARDIOLOGY, 2010, 51 (06) : 544 - 545
  • [3] Morbidity and mortality following early administration of amiodarone in acute myocardial infarction
    Elizari, MV
    Martínez, JM
    Belziti, C
    Ciruzzi, M
    de la Hoz, RP
    Sinisi, A
    Carbajales, J
    Scapín, O
    Garguichevich, J
    Girotti, L
    Cagide, A
    EUROPEAN HEART JOURNAL, 2000, 21 (03) : 198 - 205
  • [4] Serum amiodarone and desethylamiodarone concentrations following nasogastric versus oral administration
    Kotake, T
    Takada, M
    Goto, T
    Komamura, K
    Kamakura, S
    Morishita, H
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2006, 31 (03) : 237 - 243
  • [5] Liver injury after the intravenous amiodarone administration in patient with impaired heart function
    Baronica, Robert
    Mrzljak, Bojana Durovic
    Pavlek, Mario
    Bogovic, Tajana Zah
    Filipovic-Grcic, Ina
    Tomasevic, Boris
    Miric, Mirjana
    Signa Vitae, 2014, 9 : 85 - 87
  • [6] RESISTANCE OF THE HAMSTER TO AMIODARONE-INDUCED PULMONARY TOXICITY FOLLOWING REPEATED INTRAPERITONEAL ADMINISTRATION
    LEEDER, RG
    EVANS, CD
    BRIEN, JF
    MASSEY, TE
    TOXICOLOGY LETTERS, 1994, 74 (01) : 51 - 59
  • [8] Amiodarone-induced thyrotoxicosis after administration of an intravenous infusion of amiodarone
    Tohooloo, Bhavna
    Jhummon, Navina P.
    Qu, Shen
    CARDIOVASCULAR ENDOCRINOLOGY, 2013, 2 (03): : 63 - 65
  • [9] Role of amiodarone in heart failure
    Afzal A.
    Jafri S.
    Borzak S.
    Heart Failure Reviews, 1997, 2 (1) : 3 - 10
  • [10] Amiodarone distribution in human tissues after long-term therapy: a case of arrhythmogenic right ventricular cardiomyopathy
    Hosaka, F
    Shiga, T
    Sakomura, Y
    Wakaumi, M
    Matsuda, N
    Kasanuki, H
    HEART AND VESSELS, 2002, 16 (04) : 154 - 156